Horizant gabapentin enacarbil regulatory update

XenoPort said FDA extended the PDUFA date for an NDA for Horizant gabapentin enacarbil to treat restless legs syndrome (RLS) to Feb. 11 from Feb. 9 because the federal government was closed for 2 days...